Ricardo Dent

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Erik S.G. Stroes, David Colquhoun, David Sullivan et al. · Journal of the American College of Cardiology · 2014 · 525 citations · Full text

Inflammation, Lipid Disorder, Statin Intolerance +8

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Frederick J. Raal, Robert P. Giugliano, Marc S. Sabatine et al. · Journal of the American College of Cardiology · 2014 · 357 citations

Inflammation, Allergy, Immunology +8

Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

Maria-Corina Șerban, Lisandro D. Colantonio, Angelika D. Manthripragada et al. · Journal of the American College of Cardiology · 2017 · 311 citations

Coronary Heart Events, Statin Intolerance, Cardiovascular Epidemiology +11

Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database

Rohini K. Hernandez, Thy P., Cathy W. Critchlow et al. · Acta Orthopaedica · 2012 · 226 citations · Full text

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Gerald F. Watts, Dick C. Chan, Ricardo Dent et al. · Circulation · 2016 · 92 citations